Qilian International Holding Group ltd Stock

$10.52

4.42%

Nasdaq, Apr 21, 08:31 pm CET

ISIN

KYG7307E1070

Symbol

BGM

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Qilian International Holding Group ltd Stock price

$11.00

+6.00 120.08% 5Y

Nasdaq, Closing price Thu, Apr 17 2025

-0.38 3.30%

ISIN

KYG7307E1070

Symbol

BGM

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Key metrics

Market capitalization	$1.07b
Enterprise Value	$1.05b
P/E (TTM) P/E ratio	negative
EV/FCF (TTM) EV/FCF	negative
EV/Sales (TTM) EV/Sales	41.95
P/S ratio (TTM) P/S ratio	42.62
P/B ratio (TTM) P/B ratio	1.86
Revenue growth (TTM) Revenue growth	-45.99%
Revenue (TTM) Revenue	$25.10m
EBIT (operating result TTM) EBIT	$-563.80k
Free Cash Flow (TTM) Free Cash Flow	$-2.25m
EPS (TTM) EPS	$-0.25
Short interest	1.14%

As a Free StocksGuide user, you can view scores for all 6,780 stocks worldwide.

Get Started for Free Today

Qilian International Holding Group ltd Stock Analysis

Unlock Scores for Free

??

Financial data from Qilian International Holding Group ltd

Income Statement P&L | Balance Sheet | Cash Flow

TTM Annually

Sep '24		+/- %
Revenue	25 25	46% 46% 100%
- Direct Costs	22 22	52% 52% 89%
Gross Profit	2.88 2.88	372% 372% 11%
- Selling and Administrative Expenses	0.84 0.84	60% 60% 3%
- Research and Development Expense	1.36 1.36	- 5%
EBITDA	0.67 0.67	146% 146% 3%
- Depreciation and Amortization	1.24 1.24	9% 9% 5%
EBIT (Operating Income) EBIT	-0.56 -0.56	78% 78% -2%
Net Profit	-1.44 -1.44	81% 81% -6%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Qilian International Holding Group ltd Stock News

Neutral

PRNewsWire

●

about 7 hours ago

BGM Group Acquires Wonder Dragon to Accelerate "Healthcare" Strategy

CHENGDU, China , April 21, 2025 /PRNewswire/ -- BGM Group Ltd. (Nasdaq: BGM) today announced that it has signed a definitive transaction agreement with the existing shareholders of Wonder Dragon Global Limited ("Wonder Dragon"), to acquire 100% of the equity interests of Wonder Dragon by issuing 38,165,290 Class A ordinary shares at a price of $2 per share, for a total transaction valuation of ...

Neutral

PRNewsWire

●

about one month ago

BGM Acquires YX to Strengthen AI Strategy for Its Intelligent Platform

CHENGDU, China , March 19, 2025 /PRNewswire/ -- BGM Group Ltd. (the "Company" or BGM) (NASDAQ: BGM) today announced that it has signed a definitive agreement with the existing shareholders of YX Management Company Ltd.

Neutral

PRNewsWire

●

about 2 months ago

BGM Group Announces Board Reshuffle: New Leadership Embarks on a Transformative Journey Amid Tech Revolution

CHENGDU, China , Feb. 28, 2025 /PRNewswire/ -- BGM Group Ltd (NASDAQ: BGM) (the "Company" or "BGM") today announced changes to its board of directors, marking the Company's entry into a new phase of technological transformation and sustainable growth. Mr. Zhanchang Xin has tendered his resignation and will step down from his role as Chairman of the Company, effective March 1, 2025.

More Qilian International Holding Group ltd News

Company Profile

Qilian International Holding Group Ltd. is a pharmaceutical and chemical company. It focuses on the development, manufacture, marketing, and sale of oxytetracycline products, licorice products, traditional Chinese medicine derivatives product, heparin product, sausage casings, and fertilizers. The company was founded on February 7, 2019 and is headquartered in Jiuquan, China.

Head office	Cayman Islands
CEO	Chen Xin
Employees	323
Founded	2019
Website	www.bgm.ltd

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now